Evidence map›Paper›PMID 32982182›Full record

ArticleDrug design, development and therapy2020

Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels.

Naeem Ur Rehman, Muzaffar Abbas, Mariya Al-Rashida, Ahmed Tokhi, Muhammad Awais Arshid, Muhammad Sona Khan, Izhar Ahmad, Khalid Rauf

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Naeem Ur RehmanDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
Muzaffar AbbasDepartment of Pharmacy, Capital University of Science and Technology (CUST), Islamabad, Pakistan.ORCID 0000-0003-1915-3480
Mariya Al-RashidaDepartment of Chemistry, Forman Christian College (A Chartered University), Lahore 54600, Pakistan.
Ahmed TokhiDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.ORCID 0000-0001-9857-9417
Muhammad Awais ArshidAga Khan University, Karachi, Pakistan.
Muhammad Sona KhanDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
Izhar AhmadDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
Khalid RaufDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.ORCID 0000-0003-3967-9623
COMSATS University Islamabad · PKAga Khan University · PKCapital University of Science and Technology · PKForman Christian College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBehavioral sensitization is a phenomenon that develops from intermittent exposure to nicotine and other psychostimulants, which often leads to heightened locomotor activity and then relapse. Sulfonamides that act as carbonic anhydrase inhibitors have a documented role in enhancing dopaminergic tone and normalizing neuroplasticity by stabilizing glutamate release.

objectiveThe aim of the current study was to explore synthetic sulfonamides derivative 4-fluoro-N-(4-sulfamoylbenzyl) benzene-sulfonamide (4-FBS) (with documented carbonic anhydrase inhibitory activity) on acquisition and expression of nicotine-induced behavioral sensitization.

methodsIn the acquisition phase, selected 5 groups of mice were exposed to saline or nicotine 0.5mg/kg intraperitoneal (i.p) for 7 consecutive days. Selected 3 groups were administered with 4-FBS 20, 40, and 60 mg/kg p.o. along with nicotine. After 3 days of the drug-free period, ie, day 11, a challenge dose of nicotine was injected to all groups except saline and locomotor activity was recorded for 30 minutes. In the expression phase, mice were exposed to saline and nicotine only 0.5 mg/kg i.p for 7 consecutive days. After 3 days of the drug-free period, ie, day 11, 4-FBS at 20, 40, and 60 mg/kg were administered to the selected groups, one hour after drug a nicotine challenge dose was administered, and locomotion was recorded. At the end of behavioral experiments, all animals were decapitated and the striatum was excised and screened for changes in adenosine levels, using HPLC-UV.

resultsTaken together, our findings showed that 4-FBS in all 3 doses, in both sets of experiments significantly attenuated nicotine-induced behavioral sensitization in mice. Additionally, 4-FBS at 60mg/kg significantly lowered the adenosine level in the striatum.

conclusionThe behavioral and adenosine modulation is promising, and more receptors level studies are warranted to explore the exact mechanism of action of 4-FBS.

Indexed as

AdenosineAdministration, OralAnimalsBehavior, AnimalBenzene DerivativesDose-Response Relationship, DrugInjections, IntraperitonealMaleMiceMice, Inbred BALB CNicotineNicotinic AntagonistsSulfonamidesAdenosineBenzene DerivativesNicotineNicotinic AntagonistsSulfonamides4-fluoro-N-(4-sulfamoylbenzyl) benzene-sulfonamide (4-FBS)adenosinedrug addictionHPLClocomotor activitynicotine sensitizationpharmacotherapy

Identifiers

PMID32982182
PMCPMC7505708
OpenAlexW3086314150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.